Prof. Mark Kleiman criticizes a NYTimes article on the use of psychedelics in treating anxiety in subjects with advanced-stage cancer. He notes the flawed central assumption of the article which is that "all "drugs" are alike, and that "drugs" have the property of dulling perception and cognition, making people less present to what is happening to them."